|
|
Volumn 346, Issue , 2013, Pages
|
|
Reports of pancreatitis are 20-30 times more likely with GLP-1 drugs, analysis finds.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADAMANTANE;
ANTIDIABETIC AGENT;
DIPEPTIDE;
DRUG DERIVATIVE;
GLUCAGON LIKE PEPTIDE 1;
LINAGLIPTIN;
PURINE DERIVATIVE;
PYRAZINE DERIVATIVE;
QUINAZOLINE DERIVATIVE;
SAXAGLIPTIN;
SITAGLIPTIN;
TRIAZOLE DERIVATIVE;
CHEMICALLY INDUCED DISORDER;
DIABETES MELLITUS;
HUMAN;
NOTE;
PANCREATITIS;
UNITED STATES;
ADAMANTANE;
DIABETES MELLITUS;
DIPEPTIDES;
GLUCAGON-LIKE PEPTIDE 1;
HUMANS;
HYPOGLYCEMIC AGENTS;
PANCREATITIS;
PURINES;
PYRAZINES;
QUINAZOLINES;
TRIAZOLES;
UNITED STATES;
|
|
EID: 84879324248
PISSN: None
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.f2607 Document Type: Note |
|
Times cited : (21)
|
|
References (0)
|
